BioNTech SE (BNTX) Income towards Parent Company (2018 - 2026)
BioNTech SE (BNTX) recorded Income towards Parent Company of -$954.07 million in Q2 2026, compared with -$437.62 million a year earlier.
Powered by 
Analysis
BioNTech SE (BNTX) Income towards Parent Company (2018 - 2026) Analysis & Trends
On a TTM basis, BioNTech SE's Income towards Parent Company came in at -$1.97 billion as of Jun 30, 2026; for FY2025, it was -$1.32 billion.
- Across earlier years, Income towards Parent Company came in at -$710.94 million in FY2024, $1 billion in FY2023 (-89.6%), $9.63 billion in FY2022 (-18.3%) and $11.77 billion in FY2021.
- The Q2 2026 figure is the lowest quarterly Income towards Parent Company in data going back to Q3 2018.
- Peak year-over-year performance for Income towards Parent Company in the last five years was growth of 728.0% in Q4 2021, against a decline of 90.3% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -$622.72 million (Q1 2026), -$355.03 million (Q4 2025) and -$33.55 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | BioNTech SE | 24.50 Bn | -34.86 Bn | 10.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -954.07 Mn |
| Mar 31, 2026 | -622.72 Mn |
| Dec 31, 2025 | -355.03 Mn |
| Sep 30, 2025 | -33.55 Mn |
| Jun 30, 2025 | -437.62 Mn |
| Mar 31, 2025 | -437.37 Mn |
| Dec 31, 2024 | 277.30 Mn |
| Sep 30, 2024 | 217.56 Mn |
| Jun 30, 2024 | -869.91 Mn |
| Mar 31, 2024 | -342.31 Mn |
| Dec 31, 2023 | 492.67 Mn |
| Sep 30, 2023 | 174.83 Mn |
| Jun 30, 2023 | -207.33 Mn |
| Mar 31, 2023 | 539.03 Mn |
| Dec 31, 2022 | 2.32 Bn |
| Sep 30, 2022 | 1.80 Bn |
| Jun 30, 2022 | 1.78 Bn |
| Mar 31, 2022 | 4.15 Bn |
| Dec 31, 2021 | 3.62 Bn |
| Sep 30, 2021 | 3.79 Bn |
API Access
BioNTech SE Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=BNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "BNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=BNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();